基于纳米乳液模板的纳米颗粒的设计与制备——综述
Design and production of nanoparticles formulated from nano-emulsion templates-a review.
作者信息
Anton Nicolas, Benoit Jean-Pierre, Saulnier Patrick
机构信息
Inserm U646, Ingénierie de la vectorisation particulaire, 10 rue A. Boquel, F-49100 Angers, France.
出版信息
J Control Release. 2008 Jun 24;128(3):185-99. doi: 10.1016/j.jconrel.2008.02.007. Epub 2008 Feb 23.
A considerable number of nanoparticle formulation methods are based on nano-emulsion templates, which in turn are generated in various ways. It must therefore be taken into account that active principles and drugs encapsulated in nanoparticles can potentially be affected by these nano-emulsion formulation processes. Such potential differences may include drug sensitivity to temperature, high-shear devices, or even contact with organic solvents. Likewise, nano-emulsion formulation processes must be chosen in function of the selected therapeutic goals of the nano-carrier suspension and its administration route. This requires the nanoparticle formulation processes (and thus the nano-emulsion formation methods) to be more adapted to the nature of the encapsulated drugs, as well as to the chosen route of administration. Offering a comprehensive review, this paper proposes a link between nano-emulsion formulation methods and nanoparticle generation, while at the same time bearing in mind the above-mentioned parameters for active molecule encapsulation. The first part will deal with the nano-emulsion template through the different formulation methods, i.e. high energy methods on the one hand, and low-energy ones (essentially spontaneous emulsification and the phase inversion temperature (PIT) method) on the other. This will be followed by a review of the different families of nanoparticles (i.e. polymeric or lipid nanospheres and nanocapsules) highlighting the links (or potential links) between these nanoparticles and the different nano-emulsion formulation methods upon which they are based.
相当数量的纳米颗粒制备方法基于纳米乳液模板,而纳米乳液模板又通过各种方式生成。因此必须考虑到,包裹在纳米颗粒中的活性成分和药物可能会受到这些纳米乳液制备过程的潜在影响。这种潜在差异可能包括药物对温度、高剪切设备甚至与有机溶剂接触的敏感性。同样,必须根据纳米载体悬浮液的选定治疗目标及其给药途径来选择纳米乳液制备工艺。这就要求纳米颗粒制备工艺(以及由此产生的纳米乳液形成方法)更适应被包裹药物的性质以及所选的给药途径。本文进行了全面综述,提出了纳米乳液制备方法与纳米颗粒生成之间的联系,同时牢记上述活性分子包裹的参数。第一部分将通过不同的制备方法来探讨纳米乳液模板,一方面是高能方法,另一方面是低能方法(主要是自发乳化和相转变温度(PIT)法)。接下来将综述不同类型的纳米颗粒(即聚合物或脂质纳米球和纳米胶囊),突出这些纳米颗粒与它们所基于的不同纳米乳液制备方法之间的联系(或潜在联系)。